Editorial

Editorial

• Talha Müezzinoglu

Bph

How can LUTS can be treated in BPH patients with high morbidity?

• Uğur Yücetaş
• Gökhan Tokdaş

Monopolar and bipolar transurethral prostate resection in surgical treatment of benign prostatic hyperplasia

• Eray Hasırcı
• Ayhan Dirim

Statin's role on protection from the benign prostatic hyperplasia and prostate cancer

• Eray Hasırcı
• A. İbrahim Oğuzülgen

Antimuscarinics in the treatment of overactive bladder: does one fit all? Can treatment be individualized?

• Ceyhun Özyurt

Robot assisted simple prostatectomy: is it rationale?

• Levent Mert Günay
• Mehmet Cemil Uygur

Does gastronomy effect the BPH risk? The relationship between BPH and obesity

• Serkan Demiryoguran
• Atilla Tan
• Gürhan Günaydin

Uropathology

Recently described and new variants of urothelial carcinoma of the urinary bladder, overview of the variants. Do we need a new classification?

• Kemal Behzatoğlu

General Urooncology

Evaluation of complications in urooncologic surgeries and recommended criterias

• Cenk Acar
• Ali Ersin Zümrütbas

An approach to dermatological side effects of targeted therapies

• Cemal Bilaç
• Sedef Bayata
• Serap Öztürkcan

Does physical activity decrease incidence of urooncologic cancers?

• Evren Süer
• Çağatay Göğüs

Psycho-Oncology

Psychiatric management strategies in bladder cancer: recommendations to urologists

• M. Ayşin Noyan

Does cancer diagnosis cause suicide? How can risk perception and reduction be done?

• Orkun Aydın
• Artuner Deveci
• Ayşen Esen-Danacı